Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome
暂无分享,去创建一个
A. Kribben | U. Dührsen | S. Herget-Rosenthal | H. Müller-Beissenhirtz | J. Novotny | J. Novotny | Ulrich Dührsen | H. Muller-Beissenhirtz
[1] A. Órfão,et al. CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review , 2004, Leukemia.
[2] G. Amir,et al. Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis , 2002, American journal of hematology.
[3] D. Hossfeld. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .
[4] M. Bissell,et al. Leukocytoreduction for acute leukemia. , 2002, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.
[5] P. Vyas,et al. Pathology and genetics: Tumours of haematopoietic and lymphoid tissues , 2001 .
[6] K. Oshimi,et al. A minor E-selectin ligand, CD65, is critical for extravascular infiltration of acute myeloid leukemia cells. , 2001, Leukemia research.
[7] J. Strahilevitz,et al. Pulmonary leukostasis: Role of perfusion lung scan in diagnosis and follow up , 2001, American journal of hematology.
[8] S. Mustjoki,et al. Intercellular adhesion molecule‐1 in extravasation of normal mononuclear and leukaemia cells , 2001, British journal of haematology.
[9] M. Schapira,et al. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. , 2001, Blood.
[10] J. Falkenburg,et al. Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: implications for adoptive immunotherapy. , 2000, Experimental hematology.
[11] P. Porcu,et al. Hyperleukocytic Leukemias and Leukostasis: A Review of Pathophysiology, Clinical Presentation and Management , 2000, Leukemia & lymphoma.
[12] P. Lacor,et al. Different expression of adhesion molecules on CD34+ cells in AML and B‐lineage ALL and their normal bone marrow counterparts , 1999, European journal of haematology.
[13] G. Ehninger,et al. Relations between IL-3-induced proliferation and in vitro cytokine secretion of bone marrow cells from AML patients. , 1999, Cytokine.
[14] J. Magaud,et al. Differential adhesiveness between blood and marrow leukemic cells having similar pattern of VLA adhesion molecule expression. , 1998, Leukemia research.
[15] N. Heerema,et al. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate , 1997, British journal of haematology.
[16] M. Reuss-Borst,et al. Differential expression of adhesion molecules in acute leukemia. , 1995, Leukemia.
[17] W. Rosenstrauch,et al. Hypoxaemia in patients with hyperleukocytosis: true or spurious, and clinical implications. , 1993, Leukemia research.
[18] T. Horie,et al. Myeloblastoma formation in acute myeloid leukemia. , 1992, Leukemia research.
[19] F. Soares,et al. Pulmonary leukostasis without hyperleukocytosis: A clinicopathologic study of 16 cases , 1992, American journal of hematology.
[20] M. Keating,et al. Acute myeloblastic leukemia with hyperleukocytosis: Risk factors for early mortality in induction , 1988, American journal of hematology.
[21] A. Nagler,et al. Acute respiratory failure in hyperleukocytotic acute myeloid leukemia: The role of perfusion lung scintigraphy , 1988, American journal of hematology.
[22] M. van Buchem,et al. Pulmonary leukostasis: radiologic-pathologic study. , 1987, Radiology.
[23] J. Dutcher,et al. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] J. Rowe,et al. 5 Hyperleukocytic leukaemia: rheological and clinical features and management , 1987 .
[25] R. Larson,et al. Acral lividosis--a sign of myeloproliferative diseases. Hyperleukocytosis syndrome in chronic myelogenous leukemia. , 1987, Archives of dermatology.
[26] D. Catovsky,et al. Priapism complicating chronic granulocytic leukemia , 1980, American journal of hematology.
[27] T. J. Myers,et al. Hyperviscosity in chronic granulocytic leukemia , 1980, Cancer.
[28] P. Suratt,et al. Pseudohypoxemia secondary to leukemia and thrombocytosis. , 1979, The New England journal of medicine.
[29] H. Gralnick,et al. Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.
[30] R. Collins,et al. INTRAVASCULAR LEUKOCYTE THROMBI AND AGGREGATES AS A CAUSE OF MORBIDITY AND MORTALITY IN LEUKEMIA , 1974, Medicine.
[31] H. M. Marvin. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. , 1964 .
[32] J. Forrester,et al. DIFFERENTIAL EXPRESSION OF ADHESION MOLECULES IN ACUTE SYMPATHETIC OPHTHALMITIS , 1994 .
[33] J. Rowe,et al. Hyperleukocytic leukaemia: rheological and clinical features and management. , 1987, Bailliere's clinical haematology.
[34] J. Rowe,et al. Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations. , 1982, Blood.
[35] C. L. Ruemke. Laboratory aids. Variability of results in differential cell counts on blood smears. , 1960, Triangle; the Sandoz journal of medical science.